Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05743790

The Role of Dietary Intake and Host Genetics in Gut Microbiome Response to Resistant Starch Consumption

Conditions: Healthy Volunteers

Sex: All
Ages: 18 Years – N/A
Healthy volunteers: 1
Phase: NA
Enrollment: 196
Sponsor: Cornell University

Location: United States

Summary

Resistant starch (RS), a type of dietary fiber, was shown to have beneficial effects on human health through its impact on microbes present in the intestine. However, the effects of RS on the gut microbiota and in turn, on human health, can vary between individuals. Consequently, everyone may not reap the same health benefits by eating high amounts of RS. Factors predicting how an individual's gut microbes as well as the beneficial metabolites produced by these microbes respond to RS supplementation would be helpful in developing precision nutrition approaches that maximize the benefits of dietary fiber intake. The objective of this study was to evaluate candidate predictors of gut microbiota response to RS supplementation.

Eligibility Criteria

Inclusion Criteria:Above 18 years of ageWilling to consume the supplements provided throughout the duration of the studyExclusion Criteria:History of diabetes, prediabetes or impaired glucose tolerance.Existing, UNTREATED, thyroid condition.Usage of systemic antibiotics (intravenous injection, intramuscular, or oral) within 6 months prior to the study.Acute disease at the time of enrollment.Chronic, clinically significant pulmonary, cardiovascular, gastrointestinal, hepatic, or renal functional abnormality.History of active UNTREATED gastrointestinal disorders or diseases including:i. Inflammatory bowel disease (IBD) ii. Ulcerative colitis (mild-moderate-severe) iii. Crohn's disease (mild- moderate-severe) iv. Indeterminate colitis v. Irritable bowel syndrome (IBS) (moderate-severe) vi. Persistent, infectious gastroenteritis, colitis or gastritis vii. Persistent or chronic diarrhea of unknown etiology viii. Clostridium difficile infection (recurrent) ix. Chronic constipationSuspected state of immunosuppression or immunodeficiency including HIV.History of bariatric surgery.Pregnant or lactating women.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05743790). StuddyBuddy aggregates publicly available trial information.